KCNN4 promotes papillary thyroid cancer cells progression via inducing epithelial-mesenchymal transition and restraining apoptosis, which suggests that KCNN4 may be a reliable diagnostic and prognostic biomarker for PTC patients [24]. Here, KCNN4 is linked to thyroid gland papillary carcinoma.